High Throughput Screening (HTS) Market Growth To $38.33 Billion Creates New Opportunities Across The Industry
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
High Throughput Screening (HTS) Market Forecast: What Value Will The Market Reach By 2030?
The high throughput screening (hts) market size has experienced substantial growth in recent years. This market is forecasted to increase from $25.26 billion in 2025 to $27.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. Historically, this growth can be ascribed to a rising demand for swift drug discovery, progress in assay technologies, increased pharmaceutical R&D investments, the growing incorporation of robotics in laboratories, and the expansion of contract research organizations.
The high throughput screening (hts) market is poised for significant expansion in the next few years. It is projected to reach $38.34 billion in 2030, growing at a compound annual growth rate (CAGR) of 8.7%. This anticipated growth throughout the forecast period is attributable to elements such as the integration of AI and machine learning in hts, the increasing prevalence of personalized medicine, a rise in investments targeting biotechnology startups, the broadening of emerging markets in Asia-Pacific, and advancements in multiplexed and label-free assay technologies. Furthermore, prominent trends anticipated during this period include the incorporation of high-throughput automation, the miniaturization of screening platforms, the advent of advanced detection technologies, the ongoing development of multiplexed assays, and the implementation of cloud-based data management solutions.
Get A Free Sample Report With In-Depth Market Insights:
High Throughput Screening (HTS) Market Growth Backed By Core Demand Fundamentals
The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the high-throughput screening (HTS) market in the future. A chronic disease is defined as a health ailment or condition that endures for an extended duration, generally exceeding three months. HTS facilitates the swift evaluation of numerous chemical substances to identify prospective drug candidates that target particular pathways or mechanisms involved in chronic diseases, which is crucial for managing them effectively over the long term. For example, data from January 2023, provided by the National Library of Medicine, a US-based government agency, projects that the population in the US aged 50 and older suffering from at least 1 chronic condition will rise to 142.66 million by the year 2050. Consequently, the escalating incidence of chronic diseases is set to stimulate growth in the high-throughput screening (HTS) market.
High Throughput Screening (HTS) Market Segmentation And Category Overview
The high throughput screening (hts) market covered in this report is segmented –
1) By Products And Services: Consumables And Reagents, Instruments, Software And Services
2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology
3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications
4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users
Subsegments:
1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents
2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices
3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services
High Throughput Screening (HTS) Market Growth Trends Reshaping The Competitive Landscape
Leading companies within the high-throughput screening market are actively developing innovative products, such as multimode plate readers, to better serve their customers with advanced functionalities. A multimode plate reader (MPR) represents a sophisticated laboratory tool utilized in high-throughput screening, enabling the analysis of biological and chemical samples within microplates by integrating multiple detection modes for diverse assays on a single platform. For example, in February 2023, PerkinElmer Inc., a US-based MedTech company, introduced its EnVision Nexus system. The EnVision Nexus system distinguishes itself as the fastest and most sensitive multimode plate reader available, specifically engineered for demanding high-throughput screening (HTS) applications to accelerate drug discovery initiatives. Through its unique technology, which includes dual detectors and optimized reagents like proprietary HTRF and AlphaLISA, combined with the newest reagent kits, the platform delivers researchers unparalleled assay flexibility, accuracy, speed, and sensitivity. Equipped with convenient walkaway options such as a plate stacker for 20 or 50 plates, or full automation and integration for continuous 24/7 workflow-driven operations, the EnVision Nexus system empowers researchers to efficiently screen millions of samples with exceptional productivity.
High Throughput Screening (HTS) Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.
View The Full High Throughput Screening (HTS) Market Report:
High Throughput Screening (HTS) Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (hts) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
